Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gillian Cannon currently holds 1,455 shares of Xenon Pharmaceuticals Inc. (XENE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gillian Cannon has been a net seller of XENE stock. They have purchased $0 and sold $63.2K worth of shares.
Gillian Cannon's most recent insider trade was on Jun 5, 2026, when they sold 1,190 shares at $53.14 per share.
Gillian Cannon serves as Executive at Xenon Pharmaceuticals Inc. (XENE). They have executed 6 insider transactions totaling $63.2K over their tenure at the company.
Gillian Cannon holds the position of Executive at Xenon Pharmaceuticals Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Gillian Cannon has shown a selling trading pattern, with $0 in total purchases and $63.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gillian Cannon was on Sep 4, 2025, when they sold $253.0K worth of CORT shares. This transaction involved 3,607 shares at $70.13 per share.
Gillian Cannon currently owns 1,455 shares of Xenon Pharmaceuticals Inc. (XENE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gillian Cannon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gillian Cannon has 6 Form 4 filings on record as an insider at Xenon Pharmaceuticals Inc..
Set alerts for Gillian Cannon and 40,000+ other insiders.